Larry Brooks, director of business innovation at Boehringer Ingelheim, took the stage in a fireside chat with Medullan EVP and Managing Director Jonathan Chen at MobiHealthNews 2016 in San Francisco last week. Brooks has been leading Boehringer’s digital health group for the past five years, and he shed some light on how the pharma company’s approach to the space has changed during that time.
“About four or five years ago, we started a group called ‘business model and healthcare innovation’,” he said. “The mandate of the team was essentially to look at how novel healthcare technologies can really have an impact on our core business. So we spent the first year really canvassing the landscape, understanding what was out there, signing a lot of deals, probably 20 or 25, and really trying to figure out the synergy between the digital health community and Boehringer as a pharmaceutical business.” Read more.
